Atlas Trials

An Observational Study to Assess the Effect of Cumulative Ribavirin Dose in Participants With Chronic Hepatitis C

Clinical trial NCT02557646 · COMPLETED

Trial details

NCT number
NCT02557646
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatitis C, Chronic
Start date
2009-05-01
Primary completion
2014-03-01
Enrollment
697

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.